Trial Profile
Efficacy of oral Vinorelbine in patients with non-small cell lung and advanced breast cancer in a real life setting in france
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Nov 2016 New trial record
- 02 Nov 2016 Results presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research